– NeuroDerm anuncia la publicación de resultados positivos del ensayo BouNDless de fase 3 que evalúa ND0612 en pacientes con enfermedad de Parkinson con fluctuaciones motoras Los datos publicados en The Lancet Neurology mostraron una eficacia favorable de ND0612 en comparación con…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.